STRONGBRIDGE BIOPHARMA plc Interest Paid, Excluding Capitalized Interest, Operating Activities
STRONGBRIDGE BIOPHARMA plc reported Interest Paid, Excluding Capitalized Interest, Operating Activities of $997.00 thousand for the 6-month period ending 2021-06-30, per its 10-Q filed 2021-08-05.
Discontinued › Cash Flow › Other Cash Flow Items
us-gaap:InterestPaidNet · last filed 2021-08-05
- STRONGBRIDGE BIOPHARMA plc interest paid, excluding capitalized interest, operating activities for the quarter ending 2021-06-30 was $498.00K.
- STRONGBRIDGE BIOPHARMA plc interest paid, excluding capitalized interest, operating activities for the quarter ending 2021-03-31 was $499.00K.
- STRONGBRIDGE BIOPHARMA plc interest paid, excluding capitalized interest, operating activities for the quarter ending 2020-12-31 was $252.00K.
- STRONGBRIDGE BIOPHARMA plc interest paid, excluding capitalized interest, operating activities for the quarter ending 2020-09-30 was $252.00K.
- STRONGBRIDGE BIOPHARMA plc interest paid, excluding capitalized interest, operating activities for fiscal 2020 was $622.00K.
- STRONGBRIDGE BIOPHARMA plc interest paid, excluding capitalized interest, operating activities for fiscal 2018 was $11.12M, a 278.94% increase from fiscal 2017.
- STRONGBRIDGE BIOPHARMA plc interest paid, excluding capitalized interest, operating activities for fiscal 2017 was $2.94M, a 14575.00% increase from fiscal 2016.
- STRONGBRIDGE BIOPHARMA plc interest paid, excluding capitalized interest, operating activities for fiscal 2016 was $20.00K.
| Period end | Interest Paid, Excluding Capitalized Interest, Operating Activities 3 month | Interest Paid, Excluding Capitalized Interest, Operating Activities 6 month | Interest Paid, Excluding Capitalized Interest, Operating Activities 9 month | Interest Paid, Excluding Capitalized Interest, Operating Activities 12 month |
|---|---|---|---|---|
| 2021-06-30 | $498.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2021-08-05 | $997.00K 10-Q · filed 2021-08-05 | $1.25M derived: sum of 3 quarters · filed 2021-08-05 | $1.50M derived: sum of 4 quarters · filed 2021-08-05 |
| 2021-03-31 | $499.00K 10-Q · filed 2021-05-12 | $751.00K derived: sum of 2 quarters · filed 2021-05-12 | $1.00M derived: sum of 3 quarters · filed 2021-05-12 | |
| 2020-12-31 | $252.00K derived: 10-K 12 month − 10-Q 9 month · filed 2021-03-03 | $504.00K derived: sum of 2 quarters · filed 2021-03-03 | $622.00K 10-K · filed 2021-03-03 | |
| 2020-09-30 | $252.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2020-10-29 | $370.00K 10-Q · filed 2020-10-29 | ||
| 2020-06-30 | $118.00K 10-Q · filed 2021-08-05 | |||
| 2018-12-31 | $5.72M derived: 10-K 12 month − 10-Q 9 month · filed 2021-03-03 | $7.62M derived: sum of 2 quarters · filed 2021-03-03 | $9.48M derived: sum of 3 quarters · filed 2021-03-03 | $11.12M 10-K · filed 2021-03-03 |
| 2018-09-30 | $1.90M derived: 10-Q 9 month − 10-Q 6 month · filed 2019-11-07 | $3.76M derived: sum of 2 quarters · filed 2019-11-07 | $5.40M 10-Q · filed 2019-11-07 | $6.28M derived: sum of 4 quarters · filed 2020-02-28 |
| 2018-06-30 | $1.86M derived: 10-Q 6 month − 10-Q 3 month · filed 2019-07-31 | $3.50M 10-Q · filed 2019-07-31 | $4.38M derived: sum of 3 quarters · filed 2020-02-28 | $5.67M derived: sum of 4 quarters · filed 2020-02-28 |
| 2018-03-31 | $1.64M 10-Q · filed 2019-05-01 | $2.52M derived: sum of 2 quarters · filed 2020-02-28 | $3.81M derived: sum of 3 quarters · filed 2020-02-28 | $4.28M derived: sum of 4 quarters · filed 2020-02-28 |
| 2017-12-31 | $876.00K derived: 10-K 12 month − 6-K 9 month · filed 2020-02-28 | $2.17M derived: sum of 2 quarters · filed 2020-02-28 | $2.64M derived: sum of 3 quarters · filed 2020-02-28 | $2.94M 10-K · filed 2020-02-28 |
| 2017-09-30 | $1.30M derived: 6-K 9 month − 10-Q 6 month · filed 2017-11-14 | $1.76M derived: sum of 2 quarters · filed 2018-08-08 | $2.06M 6-K · filed 2017-11-14 | |
| 2017-06-30 | $467.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2018-08-08 | $762.00K 10-Q · filed 2018-08-08 | ||
| 2017-03-31 | $295.00K 10-Q · filed 2018-05-10 | |||
| 2016-12-31 | $20.00K 10-K · filed 2019-02-27 |